Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Siemens Healthineers Obtains CE Mark for Laboratory-Based, High-Throughput Antigen Test

Siemens Healthineers Obtains CE Mark for Laboratory-Based, High-Throughput Antigen Test

Feb 23, 2021
|
staff reporter

NEW YORK ─ Siemens Healthineers on Tuesday announced it has obtained CE marking for its laboratory-based SARS-CoV-2 Antigen Assay, called CoV2Ag, making it available in Europe and other regions that accept the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Dx Developers Hedge on SARS-Cov-2 Rapid Antigen Tests, Citing Conflicting FDA Messages

    Premium

  2. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  3. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  4. Abbott SARS-CoV-2 IgG Antibody Test Receives Emergency Use Authorization from FDA

  5. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.